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ABSTRACTSthe number of varicosities before and after the tourniquet Trendelenberg test
was recorded. All patients underwent EVAof the GSV under local anaesthetic
without stab avulsions. At 6-weeks post-EVA, the number of residual vari-
cosities were recorded and compared to the pre-operative ﬁndings.
Results: Themean number of varicosities observed pre-EVAwas 5.7 (range
1-11) before and 1.5 (SD 1.4) after the Trendelenberg Test, versus 1.4 (SD
1.2) post-EVA. Mean difference between the pre-EVA and post-EVA groups
was -0.2 (95% CI -0.7 - 0.4); p¼0.55 (paired T-test). The Trendelenberg test
showed a positive correlation in predicting the number of varicosities
post-EVA (pearson coefﬁcient: 0.64; p<0.001).
Conclusions: The tourniquet test is a valuable bedside tool in determining
the outcome post-EVA and the need for stab avulsions.
0753: RUPTURED ABDOMINAL AORTIC ANEURYSMS: DECREASING
INCIDENCE MAY AFFECT THE IMPACT OF SCREENING
Stephan Dreyer, Paul Burns. Department of Vascular Surgery, Royal
Inﬁrmary of Edinburgh, Edinburgh, UK
Background: Ruptured Abdominal Aortic Aneurysm (AAA) is a signiﬁcant
cause of death and recent evidence has shown that screening is beneﬁcial
in reducing mortality.
Aim: The aim of this study was to evaluate the number of ruptured AAAs,
and the associated mortality, that presented to a tertiary vascular surgery
unit each year.
Methods: A retrospective review of operative records from 1987-2009 was
conducted.
Results: 888 Patients (Male 728, Female 158) were identiﬁed. The number
of ruptures remained constant from 1987-2001, with a mean of 43.4
ruptures a year (95% CI 40.1-46.7). This decreased to a mean of 29.63 per
annum (95% CI 24.3-34.6) in 2002-2009. The average mortality was 39.8%
and showed no signiﬁcant decrease; a mean of 41.1% (95% CI 38-44.2) in
1995-2001 and 38.6% (95% CI 33.4-43.8) during the period 2002-2009.
Conclusion: This data series showed patients that reach hospital have
a signiﬁcant mortality which has not decreased during the study period.
This study further suggests that the incidence of ruptured AAAs is
decreasing. These results suggest that AAA screening may not be as
beneﬁcial and cost effective as previous studies have shown.
0808: ENDOVENOUS RADIOFREQUENCY ABLATION IN OCTOGENARIANS
– SAFE, EFFECTIVE AND RECOMMENDED
Victor Kung 1, Bynvant Sandhu 1, Andrew Choong 2, Alexander
Loh 1. 1Barnet General Hospital, Barnet, Hertfordshire, UK; 2Northwick Park
Hospital, Harrow, London, UK
Aim: Varicose vein surgery aims to reduce venous ulcer recurrence and
encourages healing to those resistant to compression therapy. However, it
is often avoided in elderly populations due tomultiple co-morbitidies. This
often results in chronic ulceration and impaired quality of life.
We report our experience of varicose vein radiofrequency ablation (RFA)
under local anaesthesia (LA) in an octogenarian population.
Method: All patients aged 80 undergoing endovenous RFA between
2009 and 2011 were identiﬁed from a prospective database. Patient
demographics, co-morbidities, indications for surgery, mode of anaes-
thesia, complications and outcomes at follow-up were documented.
Results: 35 patients (Median age 84.5, M:F¼1:1.33) had endovenous RFA,
with an ASA grade 2 (57%, n¼20) and 3 (43%, n¼15). 12 patients had active
ulcers and 7 had ulcers previously. The majority of operations (69%, n¼24)
wereperformedunder LA (1 Spinal,10GA). Therewasnooperativemortality
or morbidity. All 12 ulcers were healed by the end of the follow-up period
(Median 51 days. Range¼8-220). Only 5 patients had oedema and 1 had
residual varicosities post-treatment. No ulcer recurrence was identiﬁed.
Conclusions: Endovenous RFA under local anaesthesia is safe, effective
and recommended in patients aged over 80 in units with suitable endo-
venous expertise.
0814: PEAK OXYGEN CONSUMPTION IS AN INDEPENDENT PREDICTOR
OF MORTALITY FOLLOWING ABDOMINAL AORTIC ANEURYSM SURGERY
Andy Kordowicz 1, Jeremy Purdell-Lewis 1, David Watson 1, Anne
Johnson 1, Julian Scott 1, Simon Howell 2. 1 Leeds Vascular Institute, The
General Inﬁrmary at Leeds, Leeds, West Yorkshire, UK; 2Academic
Department of Anaesthesia, The General Inﬁrmary at Leeds, Leeds, West
Yorkshire, UKAims:We examined whether peak oxygen consumption (VO2peak) was an
independent predictor of long-term outcome after abdominal aortic
aneurysm (AAA) repair.
Methods: Between 02/2007 and 09/2009,115 patients (mean age 74.8years)
underwent static echocardiography and cardiopulmonary exercise testing
before AAA surgery. Lee scores were calculated for each patient. Mortality
data were determined from our database; median follow-up was 932days.
Using Cox-regression analysis the associations between VO2peak, anaerobic
threshold (AT) and all-cause mortality were examined.
Results: 59 open and 56 endovascular AAA repairs were performed. 30-
day mortality was 3.5% and 12-month mortality was 11.3%. 25 patients had
died by 05/2011 giving a long-term series mortality of 21.7%.
The unadjusted hazard ratio (HR) for all-cause mortality was 0.89(95%
conﬁdence intervals(CI)¼0.82-0.97) for every ml/kg/min reduction of
VO2peak(p¼0.009). This remained signiﬁcant when adjusted for age , sex ,
Lee score and performance on static echocardiogram (HR 0.90(CI¼0.82-
0.99),p¼0.033).
The association between AT and mortality was not statistically sig-
niﬁcant(HR 0.91(CI¼0.80-1.04), p¼0.187). The association between left
ventricular function and mortality was not statistically signiﬁcant (HR
2.1(CI¼0.91-4.71),p¼ 0.080).
Conclusion: VO2peak is an independent predictor of all-cause mortality
following AAA repair. A dynamic exercise test to volitional exhaustion adds
value in risk stratiﬁcation prior to AAA surgery.
0828: PREVALENCE OF AAA IN NORTH CENTRAL LONDON – FIRST YEAR
RESULTS
Bhavina Khatani, Jason Constantinou, Perbinder Grewal, Meryl
Davis. Royal Free Hospital, London, UK
Aim: The National Health Service Abdominal Aorta Aneurysm Screening
Programme (NAAASP) was announced in January 2008. North Central
London was approved in the ﬁrst phase of AAA screening implementation
and commenced screening in September 2010.
Method:Men aged 65 years resident in North Central Londonwere invited
for aneurysm screening. Data collected from 01 December 2010 for 12
months are reported.
Results: 11785 men were invited, this included ﬁrst and numerous recall
invitations; 4496 (38%) attended while 1620 (13%) declined to be screened
and 5082 (43%) did not attend.
Forty (0.9%) aneurysms were detected: with one man requiring surgery;
this was performed endovascularly and is alive 4 months postoperatively.
Conclusion: In North Central London the prevalence of screened AAA
(0.9%) is far lower than the rate in the MASS trial (4.9%). Possible reasons
for this are the younger age screened as compared to those recruited to the
MASS trial. The high DNA rates may hide the true prevalence of aneurysms.
It is noted, however that nationally the prevalence of AAA remains low.
Further work is needed to improve attendance rates for aneurysm
screening in London and this may well provide a more accurate AAA
prevalence rate.
0849: ENDOVENOUS LASER ABLATION FOR SMALL SAPHENOUS
VARICOSE VEINS: EVALUATION OF OUTCOMES OVER TWO YEAR
FOLLOW-UP
Nehemiah Samuel, Tom Wallace, Rachel Barnes, Risha Gohil, Ian
Chetter. Hull York Medical School / University of Hull, Hull, UK
Aim: To evaluate the safety and efﬁcacy of endovenous laser ablatio-
n(EVLA)as an alternative to conventional surgery for small saphenous
vein(SSV) incompetence.
Methods: Patients with symptomatic, unilateral, primary saphenopopli-
teal junction(SPJ) incompetence with SSV reﬂux receiving EVLA(810 nm
diode laser) treatment were included. Patients were assessed at baseline
and at 1,6,12,52 & 104 weeks. Outcomemeasures included: Venous Clinical
Severity Score(VCSS); Quality of life(generic-SF36, EQ5D and disease
speciﬁc-AVVQ) measures; complications and recurrence rates.
Results: 62 patients(37 women), mean age 46.3(s.d. 13.3) years were
assessed. Initial technical success was 100% in all limbs. SPJ incompetence
was abolished in 83% & 89%; and treated SSV occluded in 83% & 84% at 1
and 2 years respectively. Clinical recurrence over same period was 11%
with 4 limbs(6.4%) developing recanalisation [median(i.q.r.) laser density
94(90-103)J/cm]. Venous severity (CEAP and VCSS), AVVQ, SF36, EQ5D
